Results 161 to 170 of about 223,220 (289)

The effects of royal jelly on human health: A narrative review of clinical studies

JSFA reports, EarlyView.
Abstract Royal jelly (RJ) is a natural bioactive substance with documented effects on human health. This narrative review synthesizes evidence from clinical and clinically relevant experimental studies evaluating the therapeutic potential of RJ.
Goras Georgios, Thrasyvoulou Andreas, Tsilimpokou Evanthia   +2 more
wiley   +1 more source

A case of systemic toxicity after intralesional methotrexate for non-melanoma skin cancer in a patient with chronic kidney disease. [PDF]

JAAD Case Rep
Lamberg O, Powers JG, Negbenebor NA.
europepmc   +1 more source

Recycling of hazelnut waste: Antidiabetic properties of soy lecithin nanoparticles and their in vitro anti‐proliferative effects in tumor cell lines

Journal of the Science of Food and Agriculture, EarlyView.
Abstract BACKGROUND Hazelnuts and foods produced using hazelnuts are consumed with pleasure, but it is important to evaluate the waste generated during hazelnut processing and determine their usage methods. RESULTS This study was conducted to determine the changes in bioactive components, bioaccessibility and antidiabetic activity of nanoparticles ...
Mehmet Ali Temiz, Emine Okumus
wiley   +1 more source

Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer. [PDF]

Life (Basel)
Chedid MF, Tregnago AC, Riva F, Prediger L, Agarwal A, Mattei J.   +5 more
europepmc   +1 more source

Performance of a Deep Learning Algorithm for Melanoma Classification Across Diverse Dermoscopic and Tele‐Dermatology Datasets

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Early detection of melanoma significantly boosts patient survival rates. Deep learning has demonstrated dermatologist‐level accuracy in assessing pigmented skin lesions by analysing images at the pixel level. However, these neural networks may face challenges with ‘real‐life’ images due to limited training data and image artefacts ...
Marianne Zanchetta, Fanny Gohard, Casandra Coltoiu, Sarah Le Naour, Marie Le Moigne, Valérie Pham‐Huu, Nicole Cochelin, Edmond Demoulins, Bryan Boule, Thibault Maho, Léonie Schroder, Nicolas Diris, Gaëlle Quereux, Brigitte Dreno, Lise Boussemart, Javier Saenz   +15 more
wiley   +1 more source

Patient-Centered Outcomes in Non-Melanoma Skin Cancer Management: A Comprehensive Review. [PDF]

J Cutan Med Surg
Udupa M, Roberge D, Zhang Huang H, Pehr K.   +3 more
europepmc   +1 more source

Cigarette Smoking and Survival of Patients with Non-Melanoma Skin Cancer: A Systematic Literature Review and Meta-Analysis. [PDF]

Cancers (Basel)
Andreon C, Gaeta A, Carretti M, Graziani A, Tosti G, Doccioli C, Saponara M, Gorini G, Suppa M, Di Maggio E, Gandini S, Caini S.   +11 more
europepmc   +1 more source

Reduced Visibility of Pigment Network Under Sub‐UV Reflectance Dermatoscopy Compared to Polarised Dermatoscopy: A Novel Diagnostic Clue to Differentiate Melanomas From Nevi

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Melanoma accounts for more than 75% of skin cancer‐related mortality. Dermatoscopy is an evidence‐based technique for earlier detection, yet differentiating melanocytic lesions remains challenging. Sub‐UV reflectance dermatoscopy (sUVRD) uses purple light (405 nm) to visualise chromophore distribution in the skin.
L. Dupont, P. Pietkiewicz, J. Anriot, P. Greco, A. Petiot‐Walch, C. Coste, E. Aurambout, S. Darnis, M. Amini‐Adle, L. Thomas   +9 more
wiley   +1 more source

Non-Melanoma Skin Cancer in Transplant Recipients: A Single-Centre Retrospective Cohort Study on the Role of Transplant Type, Immunosuppressive Exposure, and Tumor Subtypes. [PDF]

Clin Transplant
Zengarini C, Tagnin V, Sorbi G, Guglielmo A, La Placa M, Piraccini BM, Pileri A, Pignatti M.   +7 more
europepmc   +1 more source

Granulomatous Panniculitis in a Patient Treated With Cemiplimab: Case Report and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Immune checkpoint inhibitors (ICIs) have become a cornerstone in the treatment of advanced malignancies by enhancing antitumor immunity, but they may also trigger a broad spectrum of immune‐related adverse events (irAEs) involving multiple organs.
B. Lada‐Colunga, J. L. Artola‐Igarza, N. Martinez‐Peña, I. Arevalo‐Ortega, J. Rodriguez‐Blandon, G. Cancho‐Galan, R. Izu‐Belloso   +6 more
wiley   +1 more source